Role of dopamine agonists in Parkinson's disease therapy
Dirk Woitalla, Carsten Buhmann, Rüdiger Hilker-Roggendorf, Günter U. Höglinger, Jiri Koschel, Thomas Müller, David Weise
Topics & Concepts
DopamineDopaminergicParkinson's diseaseLevodopaDopamine receptorDopamine agonistMedicineDopamine receptor D3AgonistNeuroscienceDopamine receptor D2DiseasePsychologyPharmacologyInternal medicineReceptorParkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsNeurotransmitter Receptor Influence on Behavior